Acrotec acquires Dawnlough

The Acrotec Group has acquired Dawnlough, based in Galway, Ireland, as its 29th company to strengthen its medical technology and aerospace capabilities.

Known for its expertise in the design and manufacture of tools and components for medical devices, particularly in the cardiovascular and robotic surgery markets, Dawnlough is at the heart of a medtech cluster where we are strengthening our presence following the acquisition of Takumi, said François Billig, CEO of the Acrotec Group.

Established in 1987, Dawnlough has grown steadily over the years, increasing its workforce and industrial space in Galway, thanks to its technological expertise in the design and high precision machining of difficult metals, combined with very fine assembly, whether for tooling for the industrialisation of medical devices, components for these devices or for the aerospace industry. Dawnlough’s design and prototyping capabilities make it Ireland’s largest supplier of custom tooling. Its machining solutions address a wide range of products and projects, from rapid prototyping for R&D projects to scalable volume production of components and assemblies, all with a focus on impeccable quality.

“We are extremely privileged and proud to have the opportunity to join such a highly esteemed group as the Acrotec Group,” says Dawnlough’s Managing Director Brian McKeon. Acrotec prides itself on upholding a set of fundamental principles, which include an entrepreneurial mindset, innovation, integrity, and independence. These values perfectly align with those of Dawnlough, making this partnership an ideal match. The collaboration between Dawnlough and Acrotec signifies a thrilling new chapter in our history that will undoubtedly bring added value and numerous opportunities for our valued customers.” G-MedTech